Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.

Oncotarget - 16 Aug 2016

Arbitrio Mariamena, Di Martino Maria Teresa, Scionti Francesca, Agapito Giuseppe, Guzzi Pietro Hiram, Cannataro Mario, Tassone Pierfrancesco, Tagliaferri Pierosandro

Abstract excerpt

In the era of personalized medicine, high-throughput technologies have allowed the investigation of genetic variations underlying the inter-individual variability in drug pharmacokinetics/pharmacodynamics. Several studies have recently moved from a candidate gene-based pharmacogenetic approach to genome-wide pharmacogenomic analyses to identify biomarkers for selection of patient-tailored therapies. In this aim,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Genotype

Share to Membrane Transport Proteins

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 27304055
DOI: 10.18632/oncotarget.9927
PMCID: PMC5288240

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.PMID 27304055Read ↗

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineSemantic proximity Read ↗

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapySemantic proximity Read ↗

Clinical Pharmacology and Pharmacogenetics in a Genomics Era: The DMET PlatformSemantic proximity Read ↗

Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies.Semantic proximity Read ↗

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.Semantic proximity Read ↗

Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation PerspectivesSemantic proximity Read ↗

Pharmacogenetics/genomics and personalized medicine.Semantic proximity Read ↗

Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical PracticeSemantic proximity Read ↗

Clinical Impact of Genetic Variants of Drug Transporters in Different Ethnic Groups within and Across RegionsSemantic proximity Read ↗

Pharmacogenetics: An Important Part of Drug Development with A Focus on Its ApplicationSemantic proximity Read ↗

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Semantic proximity Read ↗

Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.